MedPath

RECOMBINATE PWS INJ 250I.U./VIAL

RECOMBINATE PWS INJ 250I.U./VIAL

Discontinued
DIN Number

02015129

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

BAXTER HEALTHCARE CORPORATION

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02015129
AIG Number0124180001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD02 COAGULATION FACTOR VIII
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANTIHEMOPHILIC FACTOR (RECOMBINANT)Active
Strength: 250 UNIT / VIAL
Monograph: ANTIHEMOPHILIC FACTOR (RECOMBINANT)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.